| Dr Carol J Debakker, MD | |
|
100 E Lancaster Ave Ste B7, Wynnewood, PA 19096-3450 | |
| (484) 476-3391 | |
| (866) 848-9001 |
| Full Name | Dr Carol J Debakker |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 39 Years |
| Location | 100 E Lancaster Ave Ste B7, Wynnewood, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861547150 | NPI | - | NPPES |
| 0517076000 | Other | PA | KEYSTONE HEALTH PLAN EAST |
| 0012504290002 | Medicaid | PA | |
| 5309920004 | Other | PA | CIGNA |
| 682747 | Other | PA | BLUE SHIELD |
| 2512771 | Other | PA | AETNA |
| 948288 | Other | PA | UNITED HEALTHCARE |
| 250012418 | Other | PA | RR MEDICARE |
| 1000695 | Other | PA | KEYSTONE MERCY HEALTH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | MD038548E (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Main Line Hospital Lankenau | Wynnewood, PA | Hospital |
| Bryn Mawr Hospital | Bryn mawr, PA | Hospital |
| Chester County Hospital | West chester, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lower Merion Rehabilitation | 0143293977 | 3 |
News Archive
The most common kind of chronically irregular heartbeat, known as atrial fibrillation, is associated with a greater risk of dementia, including Alzheimer's disease. This discovery by scientists at Group Health Research Institute and their collaborators was published online in advance of print on August 1 in the Journal of the American Geriatrics Society.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that it has secured $10 million in financing with strategic accredited investors, including IDG-Accel China Growth Fund II L.P., Emerging Technology Partners, LLC, and Dr. Tak W. Mak, Director of The Campbell Family Institute for Cancer Research.
Researchers at Queen's University Belfast have developed a highly innovative new enzyme biomarker test that has the potential to indicate diseases and bacterial contamination saving time, money and possibly lives.
As the coronavirus disease (COVID-19) pandemic continues to spread and wreak havoc globally, another health threat emerged in China. The country has reported its first confirmed case of the rare H10N3 bird flu in a patient admitted to the hospital in April 2021 in Zhenjiang, China.
The bacterium that causes Legionnaires' disease remains difficult to track. French researchers have now developed a new technique that should allow living representatives of this dangerous pathogen to be detected much more quickly than with conventional methods. As they report in the journal Angewandte Chemie, samples are exposed to an azide-modified compound that the pathogen specifically incorporates into its shell, which is made of saccharide units. A fluorescent marker attached to the azide groups is used to identify the pathogen.
› Verified 6 days ago
| Entity Name | Lower Merion Rehabilitation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447305776 PECOS PAC ID: 0143293977 Enrollment ID: O20040818001109 |
News Archive
The most common kind of chronically irregular heartbeat, known as atrial fibrillation, is associated with a greater risk of dementia, including Alzheimer's disease. This discovery by scientists at Group Health Research Institute and their collaborators was published online in advance of print on August 1 in the Journal of the American Geriatrics Society.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that it has secured $10 million in financing with strategic accredited investors, including IDG-Accel China Growth Fund II L.P., Emerging Technology Partners, LLC, and Dr. Tak W. Mak, Director of The Campbell Family Institute for Cancer Research.
Researchers at Queen's University Belfast have developed a highly innovative new enzyme biomarker test that has the potential to indicate diseases and bacterial contamination saving time, money and possibly lives.
As the coronavirus disease (COVID-19) pandemic continues to spread and wreak havoc globally, another health threat emerged in China. The country has reported its first confirmed case of the rare H10N3 bird flu in a patient admitted to the hospital in April 2021 in Zhenjiang, China.
The bacterium that causes Legionnaires' disease remains difficult to track. French researchers have now developed a new technique that should allow living representatives of this dangerous pathogen to be detected much more quickly than with conventional methods. As they report in the journal Angewandte Chemie, samples are exposed to an azide-modified compound that the pathogen specifically incorporates into its shell, which is made of saccharide units. A fluorescent marker attached to the azide groups is used to identify the pathogen.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Carol J Debakker, MD Po Box 457, Wynnewood, PA 19096-0457 Ph: (484) 476-3391 | Dr Carol J Debakker, MD 100 E Lancaster Ave Ste B7, Wynnewood, PA 19096-3450 Ph: (484) 476-3391 |
News Archive
The most common kind of chronically irregular heartbeat, known as atrial fibrillation, is associated with a greater risk of dementia, including Alzheimer's disease. This discovery by scientists at Group Health Research Institute and their collaborators was published online in advance of print on August 1 in the Journal of the American Geriatrics Society.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that it has secured $10 million in financing with strategic accredited investors, including IDG-Accel China Growth Fund II L.P., Emerging Technology Partners, LLC, and Dr. Tak W. Mak, Director of The Campbell Family Institute for Cancer Research.
Researchers at Queen's University Belfast have developed a highly innovative new enzyme biomarker test that has the potential to indicate diseases and bacterial contamination saving time, money and possibly lives.
As the coronavirus disease (COVID-19) pandemic continues to spread and wreak havoc globally, another health threat emerged in China. The country has reported its first confirmed case of the rare H10N3 bird flu in a patient admitted to the hospital in April 2021 in Zhenjiang, China.
The bacterium that causes Legionnaires' disease remains difficult to track. French researchers have now developed a new technique that should allow living representatives of this dangerous pathogen to be detected much more quickly than with conventional methods. As they report in the journal Angewandte Chemie, samples are exposed to an azide-modified compound that the pathogen specifically incorporates into its shell, which is made of saccharide units. A fluorescent marker attached to the azide groups is used to identify the pathogen.
› Verified 6 days ago
Dr. Angela V. D'orsi, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 100 E Lancaster Ave Ste B7, Wynnewood, PA 19096 Phone: 484-476-3391 Fax: 866-848-9001 | |
Danielle Dolores Forster, D.O. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 300 E Lancaster Ave Ste 201b, Wynnewood, PA 19096 Phone: 215-874-5559 | |
Dr. Larry N. Bernstein, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 100 E Lancaster Ave, Lankenau Hospital - Pmr Dept., Wynnewood, PA 19096 Phone: 484-476-3391 Fax: 484-476-8005 | |
Philip Jerome Koehler Iii, DO Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 100 E Lancaster Ave Ste 456, Wynnewood, PA 19096 Phone: 800-321-9999 | |
Dr. Jay W. Siegfried, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 100 E Lancaster Ave, Lankenau Hospital - Pmr Dept., Wynnewood, PA 19096 Phone: 610-645-2983 Fax: 610-645-8005 | |
Dr. Kathryn Zakrzewski, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 100 E Lancaster Ave Ste B7, Wynnewood, PA 19096 Phone: 484-476-3391 |